Viewing StudyNCT00052013



Ignite Creation Date: 2024-05-05 @ 11:28 AM
Last Modification Date: 2024-10-26 @ 9:08 AM
Study NCT ID: NCT00052013
Status: COMPLETED
Last Update Posted: 2017-03-06
First Post: 2003-01-21

Brief Title: Treatment of Von Hippel-Lindau VHL-Related Hemangioblastoma With PTK787ZK 222584
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Von Hippel-Lindau Disease
CNS Hemangioblastoma
Retinal Hemangioblastoma
Keywords:
Name View
retinal View
von Hippel-Lindau disease View
CNS View
hemangioblastoma View